2021 Form 10-K Financial Statement

#000149315222010079 Filed on April 15, 2022

View on sec.gov

Income Statement

Concept 2021 2020
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.496M $1.646M
YoY Change -9.11%
% of Gross Profit
Research & Development $747.8K $431.6K
YoY Change 73.28%
% of Gross Profit
Depreciation & Amortization $0.00
YoY Change
% of Gross Profit
Operating Expenses $2.177M $2.078M
YoY Change 4.75%
Operating Profit
YoY Change
Interest Expense $2.619K
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$2.179M -$2.078M
YoY Change 4.87%
Income Tax
% Of Pretax Income
Net Earnings -$2.179M -$2.078M
YoY Change 4.88%
Net Earnings / Revenue
Basic Earnings Per Share -$0.05
Diluted Earnings Per Share -$0.15 -$0.15
COMMON SHARES
Basic Shares Outstanding 41.25M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.950K $2.220K
YoY Change 122.97%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $0.00 $43.79K
YoY Change -100.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $4.950K $61.08K
YoY Change -91.9%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $4.950K $61.08K
Total Long-Term Assets $0.00 $0.00
Total Assets $4.950K $61.08K
YoY Change -91.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $251.3K $141.4K
YoY Change 77.67%
Accrued Expenses $2.620K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $73.00K $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $469.6K $141.4K
YoY Change 232.05%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $469.6K $141.4K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $469.6K $141.4K
YoY Change 232.05%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$464.7K -$80.36K
YoY Change
Total Liabilities & Shareholders Equity $4.950K $61.08K
YoY Change -91.9%

Cashflow Statement

Concept 2021 2020
OPERATING ACTIVITIES
Net Income -$2.179M -$2.078M
YoY Change 4.88%
Depreciation, Depletion And Amortization $0.00
YoY Change
Cash From Operating Activities -$1.167M -$1.422M
YoY Change -17.95%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $1.170M 1.370M
YoY Change -14.63%
NET CHANGE
Cash From Operating Activities -$1.167M -1.422M
Cash From Investing Activities
Cash From Financing Activities $1.170M 1.370M
Net Change In Cash $2.728K -52.16K
YoY Change -105.23%
FREE CASH FLOW
Cash From Operating Activities -$1.167M -$1.422M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 RGTS Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceExercised
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
USD
CY2021Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
USD
CY2020Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
USD
CY2020Q4 us-gaap Loans Payable Current
LoansPayableCurrent
USD
CY2020Q4 us-gaap Interest Payable Current
InterestPayableCurrent
USD
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
USD
CY2021Q4 us-gaap Preferred Stock Shares Subscribed But Unissued Subscriptions Receivable
PreferredStockSharesSubscribedButUnissuedSubscriptionsReceivable
USD
CY2020 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
USD
CY2021 RGTS Stock Issued During Period Value For Exchange Of Shares
StockIssuedDuringPeriodValueForExchangeOfShares
USD
CY2021 RGTS Stock Issued During Period Value For Recission Of Preferred Stock
StockIssuedDuringPeriodValueForRecissionOfPreferredStock
USD
CY2020 RGTS Increase In Accrued Interest Payable
IncreaseInAccruedInterestPayable
USD
CY2020 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
USD
CY2020 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
USD
CY2021 RGTS Change In Stockholders Refund Payable
ChangeInStockholdersRefundPayable
USD
CY2020 RGTS Llc For Prefunded Warrants
LLCForPrefundedWarrants
USD
CY2020 RGTS Llc For Prefunded Warrants
LLCForPrefundedWarrants
USD
CY2019Q4 RGTS Due To Related Parties
DueToRelatedParties
USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
CY2020 RGTS Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceGranted
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
shares
CY2020 RGTS Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price Cancelled
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceCancelled
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
shares
CY2021 RGTS Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price Cancelled
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePriceCancelled

Files In Submission

Name View Source Status
0001493152-22-010079-index-headers.html Edgar Link pending
0001493152-22-010079-index.html Edgar Link pending
0001493152-22-010079.txt Edgar Link pending
0001493152-22-010079-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex4-1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
form10-k_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rgts-20211231.xsd Edgar Link pending
rgts-20211231_cal.xml Edgar Link unprocessable
rgts-20211231_def.xml Edgar Link unprocessable
rgts-20211231_lab.xml Edgar Link unprocessable
rgts-20211231_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending